Mar 7, 2019
Dr. Rodney Ellis has been named chair of the Department of Radiation Oncology at Penn State Health Milton S. Hershey Medical Center and Penn State College of Medicine, effective July 1.
Mar 5, 2019
The Penn State Health Board of Directors has appointed Stephen M. Massini to the role of chief executive officer for Penn State Health. The appointment becomes effective upon the retirement […]
Feb 27, 2019
The Red Lion man was diagnosed with myelodysplastic syndrome—a pre-leukemic syndrome—in October 2012 and given the choice of a stem cell transplant or other treatment alternatives that may have resulted in about two more years of life.
Feb 22, 2019
To support ongoing growth and evolving functions of Penn State Health and Penn State College of Medicine, the University’s Board of Trustees today (Feb. 22) approved an action taken recently […]
Feb 21, 2019
Dr. Craig Hillemeier, dean of Penn State College of Medicine, Penn State’s senior vice president for health affairs and chief executive officer of Penn State Health, has announced his upcoming retirement.
Feb 14, 2019
The PA Breast Cancer Coalition awarded Dr. David Waning of Penn State Cancer Institute $50,000 to advance his studies of metastatic breast cancer treatment.
Feb 13, 2019
For the research investigators and physicians who make up the Four Diamonds Pediatric Cancer Research Center at Penn State Children’s Hospital, the impact of THON is felt long after the 46-hour dance marathon is over.
Feb 6, 2019
Penn State College of Medicine researchers say some cannabinoid compounds may inhibit the growth of colon cancer cells in the lab.
Feb 5, 2019
The American Cancer Society has awarded $728,000 in funding to Penn State College of Medicine researcher Shirley Bluethmann to study whether exercise reduces joint pain and increases adherence to a type of lifesaving medication called aromatase inhibitors in women who have survived breast cancer.
Feb 4, 2019
The incidence of thyroid cancer was associated with malpractice payouts in a recent study by Penn State Cancer Institute researchers. Because thyroid cancer is not usually fatal, the findings suggest that physicians sometimes offer unnecessary testing to avoid being sued.
